ARTICLE | Financial News
Epizyme amends IPO
May 20, 2013 7:00 AM UTC
Epizyme Inc., Cambridge, Mass. Business: Cancer Date announced: 5/13/13 Type: IPO To be raised: Up to $69 million Shares: 4.3 million Price: TBD Underwriters: Citigroup; Cowen; Leerink; JMP Securities...